These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34455918)

  • 41. The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/β-catenin pathway.
    Kang R; Yao DF; Xu GZ; Zhou YH
    Neoplasma; 2020 Sep; 67(5):1094-1105. PubMed ID: 32538668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long non-coding RNA OIP5-AS1 serves as an oncogene in laryngeal squamous cell carcinoma by regulating miR-204-5p/ZEB1 axis.
    Wang H; Qian J; Xia X; Ye B
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2177-2184. PubMed ID: 32009213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CDR1as is overexpressed in laryngeal squamous cell carcinoma to promote the tumour's progression via miR-7 signals.
    Zhang J; Hu H; Zhao Y; Zhao Y
    Cell Prolif; 2018 Dec; 51(6):e12521. PubMed ID: 30182381
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
    Jili S; Eryong L; Lijuan L; Chao Z
    Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circular RNA CircSHKBP1 accelerates the proliferation, invasion, angiogenesis, and stem cell-like properties via modulation of microR-766-5p/high mobility group AT-hook 2 axis in laryngeal squamous cell carcinoma.
    Chen F; Zhang H; Wang J
    Bioengineered; 2022 May; 13(5):11551-11563. PubMed ID: 35502885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular mechanism of targeted inhibition of HMGA2 via miRNAlet-7a in proliferation and metastasis of laryngeal squamous cell carcinoma.
    Ma LJ; Wu J; Zhou E; Yin J; Xiao XP
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32432318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. lncRNA RASSF8‑AS1 suppresses the progression of laryngeal squamous cell carcinoma via targeting the miR‑664b‑3p/TLE1 axis.
    Liu T; Meng W; Cao H; Chi W; Zhao L; Cui W; Yin H; Wang B
    Oncol Rep; 2020 Nov; 44(5):2031-2044. PubMed ID: 33000257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circular RNA CircCACTIN Promotes Gastric Cancer Progression by Sponging MiR-331-3p and Regulating TGFBR1 Expression.
    Zhang L; Song X; Chen X; Wang Q; Zheng X; Wu C; Jiang J
    Int J Biol Sci; 2019; 15(5):1091-1103. PubMed ID: 31182928
    [No Abstract]   [Full Text] [Related]  

  • 49. IGF2BP2-m6A-circMMP9 axis recruits ETS1 to promote TRIM59 transcription in laryngeal squamous cell carcinoma.
    Li J; Cao H; Yang J; Wang B
    Sci Rep; 2024 Feb; 14(1):3014. PubMed ID: 38321126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low expression of lncRNA SBF2-AS1 regulates the miR-302b-3p/TGFBR2 axis, promoting metastasis in laryngeal cancer.
    Li Y; Tang B; Lyu K; Yue H; Wei F; Xu Y; Chen S; Lin Y; Cai Z; Guo X; Li C; Lei W
    Mol Carcinog; 2022 Jan; 61(1):45-58. PubMed ID: 34644425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circular RNA ABCB10 contributes to laryngeal squamous cell carcinoma (LSCC) progression by modulating the miR-588/CXCR4 axis.
    Zhao J; Li XD; Wang M; Song LN; Zhao MJ
    Aging (Albany NY); 2021 May; 13(10):14078-14087. PubMed ID: 34015764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long noncoding RNA LINC01194 enhances the malignancy of laryngeal squamous cell carcinoma by sponging miR-655 to increase SOX18 expression.
    Liu DM; Yang H; Yuan ZN; Yang XG; Pei R; He HJ
    Biochem Biophys Res Commun; 2020 Aug; 529(2):148-155. PubMed ID: 32703403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circ-PTPDC1 promotes the Progression of Gastric Cancer through Sponging Mir-139-3p by Regulating ELK1 and Functions as a Prognostic Biomarker.
    Li Z; Cheng Y; Fu K; Lin Q; Zhao T; Tang W; Xi L; Sheng L; Zhang H; Sun Y
    Int J Biol Sci; 2021; 17(15):4285-4304. PubMed ID: 34803498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. circRNA circ-CCND1 promotes the proliferation of laryngeal squamous cell carcinoma through elevating CCND1 expression via interacting with HuR and miR-646.
    Zang Y; Li J; Wan B; Tai Y
    J Cell Mol Med; 2020 Feb; 24(4):2423-2433. PubMed ID: 31951319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum-derived extracellular vesicles mediate Smad4 expression through shuttling microRNA-27a in the progression of laryngeal squamous cell carcinoma.
    Shuang Y; Yao X; Liu J; Niu J; Guo W; Li C
    Hum Cell; 2022 Jul; 35(4):1084-1099. PubMed ID: 35545731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-4497 functions as a tumor suppressor in laryngeal squamous cell carcinoma via negatively modulation the GBX2.
    Chen X; Zhang L; Tang S
    Auris Nasus Larynx; 2019 Feb; 46(1):106-113. PubMed ID: 29843929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-330-3p represses the proliferation and invasion of laryngeal squamous cell carcinoma through downregulation of Tra2β-mediated Akt signaling.
    Cheng Y; Zhu H; Gao W
    Mol Cell Probes; 2020 Aug; 52():101574. PubMed ID: 32289378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long noncoding RNA LINC01638 contributes to laryngeal squamous cell cancer progression by modulating miR-523-5p/BATF3 axis.
    Zhang H; Zhao X; Wang M; Ji W
    Aging (Albany NY); 2021 Mar; 13(6):8611-8619. PubMed ID: 33714208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.
    Fang R; Huang Y; Xie J; Zhang J; Ji X
    Diagn Pathol; 2019 Oct; 14(1):109. PubMed ID: 31615536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-365a-3p promotes tumor growth and metastasis in laryngeal squamous cell carcinoma.
    Geng J; Liu Y; Jin Y; Tai J; Zhang J; Xiao X; Chu P; Yu Y; Wang SC; Lu J; Han S; Shi J; Guo Y; Ni X
    Oncol Rep; 2016 Apr; 35(4):2017-26. PubMed ID: 26883008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.